Glucagon-like Peptide-1 Receptor Agonists
The consequences become evident in several ways: Reduced blood sugar control - As potency diminishes, patients may experience poor glucose management, potentially leading to hyperglycemia Decreased weight management results - The appetite-suppressing effects may weaken Unexpected side effects - Partially degraded medication can cause side effects not typically seen with properly stored semaglutide Bacterial contamination risk - Particularly for injectable formulations stored at improper temperatures Physical changes often signal degradation has occurred
Common adverse effects include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort, particularly during the initial weeks of treatment
Any symptoms suggesting thyroid hormone imbalancesuch as new or worsening fatigue, palpitations, heat or cold intolerance, or changes in weight beyond expected GLP-1 effectsshould prompt thyroid function testing and clinical reassessment
Semaglutide is administered once weekly, enhancing adherence for patients compared to liraglutide, which requires daily injections
Employment Records: To prove lost wages or future income loss, you must provide pay stubs or other employment records
